Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Vairo

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Minerva Dietologica E Gastroenterologica|April 1, 1980
[Experimental cholestasis, behavior of body functions and reactivity to various drugs]F Di Mezza, L Giordano, C Vacca, et al.
Cold Spring Harbor Symposia on Quantitative Biology|March 10, 2001
Control of apoptosis in hematopoietic cells by the Bcl-2 family of proteinsJ M Adams, D C Huang, H Puthalakath, et al.
Leukemia|April 8, 2014
Targeting of acute myeloid leukemia in vitro and in vivo with an anti-CD123 mAb engineered for optimal ADCCS J Busfield, M Biondo, M Wong, et al.
Leukemia|February 23, 2016
TGF-α and IL-6 plasma levels selectively identify CML patients who fail to achieve an early molecular response or progress in the first year of therapyE Nievergall, J Reynolds, C H Kok, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Minerva Dietologica E Gastroenterologica|April 1, 1980
[Experimental cholestasis, behavior of body functions and reactivity to various drugs]F Di Mezza, L Giordano, C Vacca, et al.
Cold Spring Harbor Symposia on Quantitative Biology|March 10, 2001
Control of apoptosis in hematopoietic cells by the Bcl-2 family of proteinsJ M Adams, D C Huang, H Puthalakath, et al.
Leukemia|April 8, 2014
Targeting of acute myeloid leukemia in vitro and in vivo with an anti-CD123 mAb engineered for optimal ADCCS J Busfield, M Biondo, M Wong, et al.
Leukemia|February 23, 2016
TGF-α and IL-6 plasma levels selectively identify CML patients who fail to achieve an early molecular response or progress in the first year of therapyE Nievergall, J Reynolds, C H Kok, et al.
Pageof 6